Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Targeting Renin–Angiotensin System Against Alzheimer’s Disease
by
Berhe, Derbew Fikadu
, Tuem, Kald Beshir
, Gebre, Abadi Kahsu
, Atey, Tesfay Mehari
, Altaye, Birhanetensay Masresha
in
ACEI
/ Alzheimer's disease
/ Amyloid precursor protein
/ amyloid β
/ Angiotensin AT1 receptors
/ Angiotensin II
/ Angiotensin-converting enzyme inhibitors
/ ARB
/ Blood pressure
/ Electrolytes
/ Enzymes
/ Hypothalamus
/ Memory
/ mRNA
/ Nervous system
/ Neurodegenerative diseases
/ Oxidative stress
/ Pathology
/ Peptides
/ Peptidyl-dipeptidase A
/ Pharmacology
/ Phosphorylation
/ Presenilin
/ Proteins
/ RAS
/ Reactive oxygen species
/ Renin
/ Secretase
/ Signal transduction
/ Tau protein
/ vascular disease
/ β-Amyloid
2018
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Targeting Renin–Angiotensin System Against Alzheimer’s Disease
by
Berhe, Derbew Fikadu
, Tuem, Kald Beshir
, Gebre, Abadi Kahsu
, Atey, Tesfay Mehari
, Altaye, Birhanetensay Masresha
in
ACEI
/ Alzheimer's disease
/ Amyloid precursor protein
/ amyloid β
/ Angiotensin AT1 receptors
/ Angiotensin II
/ Angiotensin-converting enzyme inhibitors
/ ARB
/ Blood pressure
/ Electrolytes
/ Enzymes
/ Hypothalamus
/ Memory
/ mRNA
/ Nervous system
/ Neurodegenerative diseases
/ Oxidative stress
/ Pathology
/ Peptides
/ Peptidyl-dipeptidase A
/ Pharmacology
/ Phosphorylation
/ Presenilin
/ Proteins
/ RAS
/ Reactive oxygen species
/ Renin
/ Secretase
/ Signal transduction
/ Tau protein
/ vascular disease
/ β-Amyloid
2018
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Targeting Renin–Angiotensin System Against Alzheimer’s Disease
by
Berhe, Derbew Fikadu
, Tuem, Kald Beshir
, Gebre, Abadi Kahsu
, Atey, Tesfay Mehari
, Altaye, Birhanetensay Masresha
in
ACEI
/ Alzheimer's disease
/ Amyloid precursor protein
/ amyloid β
/ Angiotensin AT1 receptors
/ Angiotensin II
/ Angiotensin-converting enzyme inhibitors
/ ARB
/ Blood pressure
/ Electrolytes
/ Enzymes
/ Hypothalamus
/ Memory
/ mRNA
/ Nervous system
/ Neurodegenerative diseases
/ Oxidative stress
/ Pathology
/ Peptides
/ Peptidyl-dipeptidase A
/ Pharmacology
/ Phosphorylation
/ Presenilin
/ Proteins
/ RAS
/ Reactive oxygen species
/ Renin
/ Secretase
/ Signal transduction
/ Tau protein
/ vascular disease
/ β-Amyloid
2018
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Targeting Renin–Angiotensin System Against Alzheimer’s Disease
Journal Article
Targeting Renin–Angiotensin System Against Alzheimer’s Disease
2018
Request Book From Autostore
and Choose the Collection Method
Overview
Renin Angiotensin System (RAS) is a hormonal system that regulates blood pressure and fluid balance through a coordinated action of renal, cardiovascular, and central nervous systems. In addition to its hemodynamic regulatory role, RAS involves in many brain activities, including memory acquisition and consolidation. This review has summarized the involvement of RAS in the pathology of Alzheimer's disease (AD), and the outcomes of treatment with RAS inhibitors. We have discussed the effect of brain RAS in the amyloid plaque (Aβ) deposition, oxidative stress, neuroinflammation, and vascular pathology which are directly and indirectly associated with AD. Angiotensin II (AngII) via AT1 receptor is reported to increase brain Aβ level via different mechanisms including increasing amyloid precursor protein (APP) mRNA, β-secretase activity, and presenilin expression. Similarly, it was associated with tau phosphorylation, and reactive oxygen species generation. However, these effects are counterbalanced by Ang II mediated AT2 signaling. The protective effect observed with angiotensin receptor blockers (ARBs) and angiotensin converting enzyme inhibitors (ACEIs) could be as the result of inhibition of Ang II signaling. ARBs also offer additional benefit by shifting the effect of Ang II toward AT2 receptor. To conclude, targeting RAS in the brain may benefit patients with AD though it still requires further in depth understanding.
This website uses cookies to ensure you get the best experience on our website.